This inventor holds 1 USPTO granted patent. Top assignees: Effector Therapeutics, Inc., Pfizer Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: David Malcolm Crowe: Innovator in Cancer Treatment
Introduction
David Malcolm Crowe is a notable inventor based in Boothwyn, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. His innovative work has led to the creation of a patent that addresses critical medical needs.
Latest Patents
David Malcolm Crowe holds a patent for "Solid forms of an eIF4E inhibitor." This invention relates to solid forms of a specific compound designed to inhibit eIF4E, which plays a role in cancer cell proliferation. The patent outlines pharmaceutical compositions that include these solid forms and methods for their use in treating cancer.
Career Highlights
Throughout his career, Crowe has worked with prominent companies in the pharmaceutical industry. He has been associated with Effector Therapeutics, Inc. and Pfizer Corporation, where he contributed to various projects aimed at advancing cancer therapies. His expertise in the field has been instrumental in the development of innovative solutions.
Collaborations
David Malcolm Crowe has collaborated with notable professionals in his field, including Kapildev Kashmirilal Arora and Wesley Dewitt Clark. These collaborations have enhanced his research and development efforts, leading to impactful advancements in cancer treatment.
Conclusion
David Malcolm Crowe's contributions to cancer treatment through his patent and work with leading pharmaceutical companies highlight his role as an innovator in the medical field. His dedication to improving patient outcomes through innovative solutions is commendable.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile